Detalhe da pesquisa
1.
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
N Engl J Med
; 379(2): 138-149, 2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29996082
2.
Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.
Pediatr Infect Dis J
; 24(1): 57-62, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15665711
3.
Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
Arch Pediatr Adolesc Med
; 159(10): 907-13, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16203934
4.
Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
PLoS One
; 10(4): e0121518, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25837802
5.
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial.
Vaccine
; 33(30): 3592-9, 2015 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26048780
6.
Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
Pediatr Infect Dis J
; 23(5): 429-35, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15131466
7.
Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers.
Pediatr Infect Dis J
; 21(10): 978-9, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12400528
8.
Quantification of residual EDU (N-ethyl-N'-(dimethylaminopropyl) carbodiimide (EDC) hydrolyzed urea derivative) and other residual by LC-MS/MS.
J Chromatogr B Analyt Technol Biomed Life Sci
; 813(1-2): 103-12, 2004 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15556522
9.
Safety and immunogenicity of a meningococcal (Groups A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine in healthy children aged 2 to 10 years in Chile.
Hum Vaccin
; 1(6): 228-31, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-17012878
10.
Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.
J Infect Dis
; 187(7): 1142-6, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12660929
11.
Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
Clin Diagn Lab Immunol
; 11(1): 1-5, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14715537
12.
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.
J Infect Dis
; 186(12): 1848-51, 2002 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12447774
13.
LC/MS characterization of meningococcal depolymerized polysaccharide group C reducing endgroup and internal repeating unit.
Anal Chem
; 76(24): 7387-90, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15595884
14.
Kinetic studies on the rate of hydrolysis of N-ethyl-N'-(dimethylaminopropyl)carbodiimide in aqueous solutions using mass spectrometry and capillary electrophoresis.
Anal Biochem
; 310(1): 122-4, 2002 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12413482